Cencora Inc
COR350.320USD
+4.320+1.25%
Handelsschluss 12/15, 16:00（ET）Kurse um 15 Minuten verzögert
67.94BMarktkapitalisierung
43.69KGV TTM
mehr Informationen über Cencora Inc Unternehmen
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Cencora Inc Informationen
BörsenkürzelCOR
Name des UnternehmensCencora Inc
IPO-datumMay 28, 1996
CEOMauch (Robert P)
Anzahl der mitarbeiter51000
WertpapierartOrdinary Share
GeschäftsjahresendeMay 28
Addresse1 West First Avenue
StadtCONSHOHOCKEN
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19428
Telefon16107277000
Websitehttps://www.cencora.com/
BörsenkürzelCOR
IPO-datumMay 28, 1996
CEOMauch (Robert P)
Führungskräfte von Cencora Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
27.24K
+112.43%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
20.47K
+80.39%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
19.11K
-13.57%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.63K
+0.83%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+23.04%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.57%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
957.00
+469.64%
Ms. Lori J. Ryerkerk
Ms. Lori J. Ryerkerk
Independent Director
Independent Director
516.00
--
Ms. Lauren M. Tyler
Ms. Lauren M. Tyler
Independent Director
Independent Director
--
--
Mr. Bennett S. Murphy
Mr. Bennett S. Murphy
Senior Vice President, Investor Relations
Senior Vice President, Investor Relations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
27.24K
+112.43%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
20.47K
+80.39%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
19.11K
-13.57%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.63K
+0.83%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+23.04%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.57%
Umsatzaufteilung
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.02%
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.74%
Walgreens Boots Alliance Inc
3.85%
T. Rowe Price Associates, Inc.
3.79%
Andere
69.00%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.02%
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.74%
Walgreens Boots Alliance Inc
3.85%
T. Rowe Price Associates, Inc.
3.79%
Andere
69.00%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
53.44%
Investment Advisor/Hedge Fund
30.19%
Corporation
3.85%
Research Firm
3.09%
Hedge Fund
2.83%
Pension Fund
2.43%
Bank and Trust
2.23%
Sovereign Wealth Fund
1.26%
Family Office
1.17%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
2325
185.17M
94.90%
+31.68K
2025Q3
2360
185.31M
95.09%
+4.64M
2025Q2
2343
180.65M
95.85%
-533.00K
2025Q1
2278
180.99M
94.03%
-1.15M
2024Q4
2205
177.00M
96.12%
-3.08M
2024Q3
2114
179.91M
93.30%
+3.58M
2024Q2
2070
176.04M
91.35%
-1.09M
2024Q1
2048
176.18M
88.49%
-350.13K
2023Q4
1964
171.90M
85.06%
+6.01M
2023Q3
1864
166.03M
82.05%
+4.34M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
22.40M
11.55%
+1.12M
+5.26%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
12.03M
6.21%
+1.02M
+9.29%
Jun 30, 2025
State Street Investment Management (US)
8.41M
4.34%
-6.73K
-0.08%
Jun 30, 2025
Walgreens Boots Alliance Inc
7.47M
3.85%
-2.91M
-28.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.46M
3.85%
-1.87M
-20.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.79M
2.47%
+284.23K
+6.31%
Jun 30, 2025
Boston Partners
4.42M
2.28%
-991.53K
-18.32%
Jun 30, 2025
Wellington Management Company, LLP
3.86M
1.99%
-1.57M
-28.88%
Jun 30, 2025
JP Morgan Asset Management
2.76M
1.43%
-110.19K
-3.83%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.78M
1.44%
+751.58K
+36.98%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
VanEck Pharmaceutical ETF
8.42%
AdvisorShares Focused Equity ETF
5.56%
First Trust Consumer Staples Alphadex Fund
3.52%
Goldman Sachs Future Health Care Equity ETF
3.48%
VanEck Retail ETF
3.31%
Hennessy Sustainable ETF
3.08%
iShares US Consumer Staples ETF
3.02%
American Century Mid Cap Growth Impact ETF
2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
2.51%
Counterpoint Quantitative Equity ETF
2.4%
Mehr Anzeigen
VanEck Pharmaceutical ETF
Anteil8.42%
AdvisorShares Focused Equity ETF
Anteil5.56%
First Trust Consumer Staples Alphadex Fund
Anteil3.52%
Goldman Sachs Future Health Care Equity ETF
Anteil3.48%
VanEck Retail ETF
Anteil3.31%
Hennessy Sustainable ETF
Anteil3.08%
iShares US Consumer Staples ETF
Anteil3.02%
American Century Mid Cap Growth Impact ETF
Anteil2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
Anteil2.51%
Counterpoint Quantitative Equity ETF
Anteil2.4%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
2.01B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 04, 2025
COR.NB Final Cash Dividend of gross USD 0.6 paid on Dec 01, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 01, 2025
Nov 14, 2025
Aug 06, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Sep 03, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 03, 2025
Aug 15, 2025
May 07, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Jun 02, 2025 going ex on May 16, 2025
May 16, 2025
Jun 02, 2025
May 16, 2025
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Nov 02, 2023
COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023
Nov 13, 2023
Nov 27, 2023
Nov 10, 2023
Aug 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023
Aug 11, 2023
Aug 28, 2023
Aug 10, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Cencora Inc?
Die fünf größten Anteilseigner von Cencora Inc sind:
The Vanguard Group, Inc. hält 22.40M Aktien, was 11.55% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 12.03M Aktien, was 6.21% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 8.41M Aktien, was 4.34% der Gesamtaktien entspricht.
Walgreens Boots Alliance Inc hält 7.47M Aktien, was 3.85% der Gesamtaktien entspricht.
T. Rowe Price Associates, Inc. hält 7.46M Aktien, was 3.85% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 22.40M Aktien, was 11.55% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 12.03M Aktien, was 6.21% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 8.41M Aktien, was 4.34% der Gesamtaktien entspricht.
Walgreens Boots Alliance Inc hält 7.47M Aktien, was 3.85% der Gesamtaktien entspricht.
T. Rowe Price Associates, Inc. hält 7.46M Aktien, was 3.85% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Cencora Inc?
Die drei wichtigsten Anteilseigner-Typen von Cencora Inc sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an Cencora Inc (COR)?
Mit Stand vom 2025Q4 halten 2325 Institutionen Anteile an Cencora Inc, mit einem Gesamtmarktwert von etwa 185.17M, was 94.90% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -0.19% gestiegen.
Was ist die größte Einnahmequelle von Cencora Inc?
Am -- erzielte das Geschäft mit -- für Cencora Inc den höchsten Umsatz in Höhe von --, was --% des Gesamtumsatzes entspricht.
